While lipopolysaccharide and PAA are the major driving forces derived from gut microbiota for NASH development, Shp deletion decreases these signaling molecules via dysbiosis, thereby partially protecting mice from diet-induced metabolic disorders. The gene discussed is NR0B2; the disease is metabolic dysfunction-associated steatohepatitis.